Assembling Your Care Team and Treatment Strategies

Managing Mandibuloacral Dysplasia (MAD) requires more than a single doctor; it requires a coordinated team of specialists who understand how this rare condition affects different parts of your body. Because MAD is a multisystem disorder, your care strategy should focus on early detection of complications and specialized management of heart, bone, and metabolic health ^[1][2].

Your Multidisciplinary Care Team

A “multidisciplinary” team means specialists from different fields working together. For MAD, your team should ideally include:

• Medical Geneticist / Genetic Counselor: To confirm your molecular subtype, discuss family inheritance risks, and provide guidance on the long-term outlook ^[1].
• Endocrinologist/Lipodystrophy Expert: To manage lipodystrophy-associated insulin resistance, diabetes, and high triglycerides (fats) ^[2][3].
• Cardiologist: To monitor for heart valve calcification (especially the aortic valve) and changes in heart muscle strength ^[4][5].
• Nephrologist: To watch for early signs of kidney strain, such as protein in the urine, particularly in the MTX2 phenotype ^[6][7].
• Orthopedist / Occupational Therapist: To manage joint stiffness, bone thinning (osteoporosis), and hand function affected by skeletal changes ^[8][2].
• Dentist/Maxillofacial Surgeon: To address dental crowding and jaw development ^[2].

Preparing for Your First Appointment

Because MAD is rare, you should act as the central “hub” for your medical information. Bring copies or secure digital access to your records to every new specialist visit:

1. Full Genetic Report: Ensure it includes the gene name, the specific variant (e.g., c.743C>T), and whether it was inherited from one or both parents ^[9].
2. Imaging Records: Provide actual copies (on a CD or digital portal) of recent X-rays, Bone Density (DEXA) scans, and Echocardiograms ^[8][4].
3. Metabolic Panels: Recent blood tests for fasting glucose, HbA1c, and a full lipid panel (cholesterol and triglycerides) ^[2].
4. Growth Charts: For younger patients, tracking growth over time is essential for the endocrinology team ^[8].

Management Strategies and Standards of Care

There is currently no “cure” for MAD, so treatment focuses on practical symptom management and addressing complications as they arise based on expert assessment ^[2].

Metabolic and Bone Health

• Metabolic Management: High triglycerides and insulin resistance are often managed with specialized diets or standard medications for diabetes and lipids ^[2]. In some specific related lipodystrophy syndromes, a medication called metreleptin has shown benefit, but its use in MAD is determined on a case-by-case basis by experts, and access depends on specific indications ^[3].
• Bone Density: While MAD involves complex bone changes, traditional treatments for osteoporosis (like bisphosphonates) are not automatically indicated for every low bone-density result. They must be carefully evaluated by a specialist, particularly for individuals with kidney disease or atypical bone development ^[10][8].

Cardiac Intervention

• Aortic Stenosis: If a heart valve becomes severely calcified and narrow, specialists may recommend valve replacement. While Transcatheter Aortic Valve Replacement (TAVR)—a less invasive way to replace the valve—has been reported in individual MAD cases to improve symptoms, the choice between surgical and transcatheter approaches depends on the patient’s age, anatomy, surgical risk, and the specialist team’s judgment ^[11][4].

Avoiding Treatment Pitfalls

Inexperienced doctors may sometimes misunderstand the unique biology of MAD. It is important to be aware of the following:

• Empiric Use of Experimental Drugs: Treatments like lonafarnib (farnesyltransferase inhibitors) or rapamycin have been studied in cell models or related conditions like Progeria, but they are experimental and not established standard of care for MAD ^[12][13].
• Growth Hormone: While some patients have a growth hormone deficiency, starting growth hormone therapy without careful expert evaluation can worsen insulin resistance and diabetes in some individuals ^[5].
• Incomplete Monitoring: A doctor may focus only on the visible skin or bone changes and miss “silent” issues like protein in the urine or heart valve calcification. Ensure your team establishes an individualized, comprehensive screening schedule ^[4][7].